OPKO Health (OPK)

OPKO Instrumentation, LLC • OPKO Pharmaceuticals, LLC • OPKO Diagnostics, LLC • ModeX Therapeutics, Inc. • OPKO Chile, S.A. • Arama Natural Products Distribuidora, Ltda • Pharmacos Exakta S.A. de C.V. • FineTech Pharmaceutical Ltd • OPKO Health Europe, S.L. • OPKO Biologics, Ltd ...

IRS number

752402409

OPK stock data

1M 3M 6M 1Y

Analyst ratings and price targets

Last 3 months

Latest filings (excl ownership)

View all

7 Nov 24

OPKO Health Reports Third Quarter 2024 Business Highlights and Financial Results

7 Nov 24

8-K

Labcorp Completes Acquisition of Select Assets of BioReference Health's Diagnostics Business

Departure of Directors or Certain Officers

26 Jul 24

8-K

OPKO Health and HealthCare Royalty Enter into $250 Million Note Purchase Agreement Secured by NGENLA’s Profit Share Payments

7 May 24

OPKO Health Reports First Quarter 2024 Business Highlights and Financial Results

7 May 24

8-K

Submission of Matters to a Vote of Security Holders

29 Mar 24

8-K/A

Regulation FD Disclosure

28 Mar 24

Transcripts

View all

OPK

Earnings call transcript

2024 Q3

7 Nov 24

OPK

Earnings call transcript

2024 Q2

7 Aug 24

OPK

Earnings call transcript

2024 Q1

7 May 24

OPK

Earnings call transcript

2023 Q4

27 Feb 24

OPK

Earnings call transcript

2023 Q3

6 Nov 23

OPK

Earnings call transcript

2023 Q2

3 Aug 23

OPK

Earnings call transcript

2023 Q2

3 Aug 23

OPK

Earnings call transcript

2023 Q1

3 May 23

OPK

Earnings call transcript

2022 Q4

23 Feb 23

OPK

Earnings call transcript

2022 Q3

8 Nov 22

Latest ownership filings

View all

PHILLIP MD ET AL FROST

13 Dec 24

PHILLIP MD ET AL FROST

11 Dec 24

PHILLIP MD ET AL FROST

29 Nov 24

PHILLIP MD ET AL FROST

22 Nov 24

SC 13D/A

GeneDx Holdings Corp.

20 Nov 24

4/A

PHILLIP MD ET AL FROST

20 Nov 24

SC 13D/A

FROST PHILLIP MD ET AL

15 Nov 24

PHILLIP MD ET AL FROST

14 Nov 24

SC 13G

Rubric Capital Management LP

Financial summary

Financial statements Chart OPK financial data

Quarter (USD)	Sep 24	Mar 24	Dec 23	Sep 23
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 23	Dec 22	Dec 21	Dec 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	420.07 mm	420.07 mm	420.07 mm	420.07 mm		420.07 mm
Cash burn (monthly)	(no burn)	(no burn)	(no burn)	15.89 mm		3.40 mm
Cash used (since last report)	n/a	n/a	n/a	44.49 mm		9.51 mm
Cash remaining	n/a	n/a	n/a	375.58 mm		410.56 mm
Runway (months of cash)	n/a	n/a	n/a	23.6		120.9

Beta Read what these cash burn values mean

Financial data from OPKO Health earnings reports.

Institutional ownership, Q2 2024

OPK institutional ownership history Ownership history

37.1% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	129	206	-37.4%
Opened positions	36	40	-10.0%
Closed positions	113	47	+140.4%
Increased positions	16	43	-62.8%
Reduced positions	33	53	-37.7%

13F shares	Current	Prev Q	Change
Total value	42.54 bn	163.30 bn	-73.9%
Total shares	287.12 mm	392.32 mm	-26.8%
Total puts	8.83 mm	849.50 k	+939.1%
Total calls	4.23 mm	2.32 mm	+82.2%
Total put/call ratio	2.1	0.4	+470.2%

Largest owners	Shares	Value	Change
Phillip MD Frost Et Al	205.87 mm	$202.00 mm	0.0%
Gary J. Nabel	19.86 mm	$48.45 mm	0.0%
Zerhouni Elias A.	19.78 mm	$48.26 mm	0.0%
STT State Street	9.55 mm	$11.94 bn	-6.4%
Hsiao Jane PH D	5.13 mm	$13.54 mm	0.0%
Voya Investment Management	3.00 mm	$3.75 bn	-2.9%
Portolan Capital Management	1.89 mm	$2.36 bn	-41.8%
BK The Bank of New York Mellon Corporation	1.39 mm	$1.74 bn	-5.1%
Norges Bank	1.33 mm	$1.66 bn	NEW
AWM Investment	1.30 mm	$1.63 bn	NEW

Largest transactions	Bought/sold	Change
BLK BlackRock	-33.23 mm	EXIT
Vanguard	-29.50 mm	EXIT
Geode Capital Management	-9.97 mm	EXIT
Rubric Capital Management	-4.94 mm	EXIT
NTRS Northern Trust	-4.77 mm	EXIT
GS The Goldman Sachs Group, Inc.	-3.12 mm	EXIT
Dimensional Fund Advisors	-2.92 mm	EXIT
HRT Financial	-1.72 mm	EXIT
JPM JPMorgan Chase & Co.	-1.59 mm	EXIT
IVZ Invesco	-1.56 mm	EXIT

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

OPK insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
13 Dec 24	Phillip MD Frost Et Al	Common Stock	Buy	Acquire P	Yes	No	1.595	125,000	199.38 k	212,536,477
11 Dec 24	Phillip MD Frost Et Al	Common Stock	Buy	Acquire P	Yes	No	1.5621	500,000	781.05 k	212,411,477
29 Nov 24	Phillip MD Frost Et Al	Common Stock	Buy	Acquire P	Yes	No	1.534	199,072	305.38 k	211,911,477
22 Nov 24	Phillip MD Frost Et Al	Common Stock	Buy	Acquire P	Yes	No	1.59	100,000	159.00 k	211,712,405
14 Nov 24	Phillip MD Frost Et Al	Common Stock	Buy	Acquire P	Yes	No	1.6198	100,000	161.98 k	211,612,405